232 related articles for article (PubMed ID: 32102684)
1. Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides.
Cui YR; Wang SJ; Chen J; Li J; Chen W; Wang S; Meng B; Zhu W; Zhang Z; Yang B; Jiang B; Yang G; Ma P; Liu J
Genome Biol; 2020 Feb; 21(1):51. PubMed ID: 32102684
[TBL] [Abstract][Full Text] [Related]
2. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
3. Potent CRISPR-Cas9 inhibitors from
Watters KE; Shivram H; Fellmann C; Lew RJ; McMahon B; Doudna JA
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6531-6539. PubMed ID: 32156733
[TBL] [Abstract][Full Text] [Related]
4. Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins.
Hoffmann MD; Aschenbrenner S; Grosse S; Rapti K; Domenger C; Fakhiri J; Mastel M; Börner K; Eils R; Grimm D; Niopek D
Nucleic Acids Res; 2019 Jul; 47(13):e75. PubMed ID: 30982889
[TBL] [Abstract][Full Text] [Related]
5. A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9.
Maji B; Gangopadhyay SA; Lee M; Shi M; Wu P; Heler R; Mok B; Lim D; Siriwardena SU; Paul B; Dančík V; Vetere A; Mesleh MF; Marraffini LA; Liu DR; Clemons PA; Wagner BK; Choudhary A
Cell; 2019 May; 177(4):1067-1079.e19. PubMed ID: 31051099
[TBL] [Abstract][Full Text] [Related]
6. Identification and Analysis of Small Molecule Inhibitors of CRISPR-Cas9 in Human Cells.
Yang Y; Li D; Wan F; Chen B; Wu G; Li F; Ren Y; Liang P; Wan J; Songyang Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429003
[TBL] [Abstract][Full Text] [Related]
7. Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing.
Garcia B; Lee J; Edraki A; Hidalgo-Reyes Y; Erwood S; Mir A; Trost CN; Seroussi U; Stanley SY; Cohn RD; Claycomb JM; Sontheimer EJ; Maxwell KL; Davidson AR
Cell Rep; 2019 Nov; 29(7):1739-1746.e5. PubMed ID: 31722192
[TBL] [Abstract][Full Text] [Related]
8. SMOOT libraries and phage-induced directed evolution of Cas9 to engineer reduced off-target activity.
Cerchione D; Loveluck K; Tillotson EL; Harbinski F; DaSilva J; Kelley CP; Keston-Smith E; Fernandez CA; Myer VE; Jayaram H; Steinberg BE
PLoS One; 2020; 15(4):e0231716. PubMed ID: 32298334
[TBL] [Abstract][Full Text] [Related]
9. Allosteric regulation of CRISPR-Cas9 for DNA-targeting and cleavage.
Zuo Z; Liu J
Curr Opin Struct Biol; 2020 Jun; 62():166-174. PubMed ID: 32070859
[TBL] [Abstract][Full Text] [Related]
10. Systematic in vitro specificity profiling reveals nicking defects in natural and engineered CRISPR-Cas9 variants.
Murugan K; Suresh SK; Seetharam AS; Severin AJ; Sashital DG
Nucleic Acids Res; 2021 Apr; 49(7):4037-4053. PubMed ID: 33744974
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
12. Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides.
Ding X; Seebeck T; Feng Y; Jiang Y; Davis GD; Chen F
CRISPR J; 2019 Feb; 2():51-63. PubMed ID: 31021236
[TBL] [Abstract][Full Text] [Related]
13. Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein.
Hoffmann MD; Mathony J; Upmeier Zu Belzen J; Harteveld Z; Aschenbrenner S; Stengl C; Grimm D; Correia BE; Eils R; Niopek D
Nucleic Acids Res; 2021 Mar; 49(5):e29. PubMed ID: 33330940
[TBL] [Abstract][Full Text] [Related]
14. Naturally Occurring Off-Switches for CRISPR-Cas9.
Pawluk A; Amrani N; Zhang Y; Garcia B; Hidalgo-Reyes Y; Lee J; Edraki A; Shah M; Sontheimer EJ; Maxwell KL; Davidson AR
Cell; 2016 Dec; 167(7):1829-1838.e9. PubMed ID: 27984730
[TBL] [Abstract][Full Text] [Related]
15. Development of aptamer-based inhibitors for CRISPR/Cas system.
Zhao J; Inomata R; Kato Y; Miyagishi M
Nucleic Acids Res; 2021 Feb; 49(3):1330-1344. PubMed ID: 33123724
[TBL] [Abstract][Full Text] [Related]
16. Recruitment of DNA Repair MRN Complex by Intrinsically Disordered Protein Domain Fused to Cas9 Improves Efficiency of CRISPR-Mediated Genome Editing.
Reuven N; Adler J; Broennimann K; Myers N; Shaul Y
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31597252
[TBL] [Abstract][Full Text] [Related]
17. Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6.
Fuchsbauer O; Swuec P; Zimberger C; Amigues B; Levesque S; Agudelo D; Duringer A; Chaves-Sanjuan A; Spinelli S; Rousseau GM; Velimirovic M; Bolognesi M; Roussel A; Cambillau C; Moineau S; Doyon Y; Goulet A
Mol Cell; 2019 Dec; 76(6):922-937.e7. PubMed ID: 31604602
[TBL] [Abstract][Full Text] [Related]
18. Cas9 degradation in human cells using phage anti-CRISPR proteins.
Meacham Z; de Tacca LA; Bondy-Denomy J; Rabuka D; Schelle M
PLoS Biol; 2023 Dec; 21(12):e3002431. PubMed ID: 38064533
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.
Rauch BJ; Silvis MR; Hultquist JF; Waters CS; McGregor MJ; Krogan NJ; Bondy-Denomy J
Cell; 2017 Jan; 168(1-2):150-158.e10. PubMed ID: 28041849
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2.
Thavalingam A; Cheng Z; Garcia B; Huang X; Shah M; Sun W; Wang M; Harrington L; Hwang S; Hidalgo-Reyes Y; Sontheimer EJ; Doudna J; Davidson AR; Moraes TF; Wang Y; Maxwell KL
Nat Commun; 2019 Jun; 10(1):2806. PubMed ID: 31243272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]